Goin Kathleen — SEC insider filings
SEC reporting owner CIK 1912570. 15 insider filings on record with FilingPulse; latest filed 2026-10-23.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-12-17 to 2026-10-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 36 legs across 12 filings — 51,635 shares, $6,043,762 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 52.
- Largest priced transaction: sale of 4,302 shares @ $96.47 ($415,023) in PALVELLA THERAPEUTICS, INC., filed 2025-12-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PALVELLA THERAPEUTICS, INC. (PVLA) | Chief Operating Officer | 15 | — | 36 legs · 51,635 sh · $6,043,762 | 52 |
Insider filings — Goin Kathleen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-23 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,165 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 2,043 @ $123.62 · Sale (S): 1,663 @ $125.16 · Sale (S): 607 @ $126.19 · Option exercise (M): 2,165 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-18 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 1,659 @ $151.16 · Sale (S): 989 @ $152.36 · Sale (S): 1,654 @ $153.24 · Option exercise (M): 2,154 (derivative) @ $0 · +1 more | EDGAR |
| 2026-08-20 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 1,500 @ $151.39 · Sale (S): 1,998 @ $151.80 · Sale (S): 400 @ $153.00 · Sale (S): 102 @ $155.59 · +3 more | EDGAR |
| 2026-07-17 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 522 @ $147.14 · Sale (S): 840 @ $148.40 · Sale (S): 1,029 @ $149.27 · Sale (S): 1,911 @ $150.25 · +2 more | EDGAR |
| 2026-06-22 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 2,390 @ $110.26 · Sale (S): 1,887 @ $111.31 · Sale (S): 25 @ $112.23 · Option exercise (M): 2,154 (derivative) @ $0 · +1 more | EDGAR |
| 2026-05-22 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 3,363 @ $110.35 · Sale (S): 891 @ $111.30 · Sale (S): 48 @ $111.89 · Option exercise (M): 2,154 (derivative) @ $0 · +1 more | EDGAR |
| 2026-04-17 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 1,502 @ $125.96 · Sale (S): 1,500 @ $127.13 · Sale (S): 561 @ $128.23 · Sale (S): 639 @ $129.17 · +3 more | EDGAR |
| 2026-03-20 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 2,268 @ $117.56 · Sale (S): 1,730 @ $118.37 · Sale (S): 304 @ $119.08 · Option exercise (M): 2,154 (derivative) @ $0 · +1 more | EDGAR |
| 2026-02-20 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 3,026 @ $79.16 · Sale (S): 1,276 @ $79.97 · Option exercise (M): 2,154 (derivative) @ $0 · Option exercise (M): 2,148 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 48,956 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 553 @ $95.49 · Sale (S): 3,749 @ $97.94 · Option exercise (M): 2,154 (derivative) @ $0 · Option exercise (M): 2,148 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 4,302 @ $96.47 · Option exercise (M): 2,154 (derivative) @ $0 · Option exercise (M): 2,148 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 1,500 @ $85.72 · Sale (S): 2,802 @ $86.51 · Option exercise (M): 2,154 (derivative) @ $0 · Option exercise (M): 2,148 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4/A | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 5,373 (derivative) @ $0 · Grant/award (A): 123,559 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 27,843 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-01-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1912570 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs